Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammato…

Overview of attention for article published in The Journal of Pharmacology and Experimental Therapeutics, April 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Combinations containing a 4-acylaminopyridine derivative

Grant US-7998971-B2

United States of America

5 HT receptor mediated neurogenesis

Grant US-7678808-B2

United States of America

[1,7]NAPHTHYRIDINES AS PDE4 INHIBITORS

Application EP-1575950-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.